e-learning
resources
London 2016
Tuesday, 06.09.2016
Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is PD1/PD-L1 Resting ready for clinical practice? Pro
Celine Mascaux (Brussels, Belgium)
Source:
International Congress 2016 – Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Session:
Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Session type:
Lunchtime session
Number:
4464
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Celine Mascaux (Brussels, Belgium). Is PD1/PD-L1 Resting ready for clinical practice? Pro. International Congress 2016 – Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Is PD1/PD-L1 Resting ready for clinical practice? Con
Source: International Congress 2016 – Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Year: 2016
Is Next Generation Sequencing Resting (NGSR) ready for clinical practice? Pro
Source: International Congress 2016 – Do we really need PD1/PD-L1 status and next generation sequencing to treat lung cancer?
Year: 2016
Blood biomarkers: ready for practice?
Source: ERS Research Seminar 2018 – Lung Cancer Screening: from Trial to Practice
Year: 2018
Telemonitoring in clinical practice: a way forward?
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013
Adaptive servoventilation in clinical practice: beyond SERVE-HF?
Source: ERJ Open Res, 3 (4) 00078-2017; 10.1183/23120541.00078-2017
Year: 2017
ACCP1 - Is telemedicine in your future?
Source: Annual Congress 2008 - MP17 - ACCP: Is telemedicine in your future?
Year: 2008
Monitoring at home - telemedicine, how and why?
Source: Annual Congress 2004 - PG21 - Home mechanical ventilation in COPD patients
Year: 2004
Anti-IgE: changing lives in clinical practice?
Source: Eur Respir Rev 2007; 16: 59-60
Year: 2007
New technologies in bronchoscopy: which are still research tools and which are ready for clinical use?
Source: Annual Congress 2010 - PG13 Core Curriculum Postgraduate Course: Interventional pulmonology
Year: 2010
Precision medicine in COPD: where are we and where do we need to go?
Source: Eur Respir Rev, 27 (149) 180022; 10.1183/16000617.0022-2018
Year: 2018
Why aren't guidelines being implemented in daily practice?
Source: Annual Congress 2010 - PG20 Postgraduate Course: Implementing asthma guidelines for children in daily practice
Year: 2010
Are patients ready for rehabilitation?
Source: Eur Respir J 2005; 26: Suppl. 49, 70s
Year: 2005
Advance care planning: state of the art and recommendations for clinical practice
Source: School Course 13
Year: 2013
How to implement the guidelines in the clinical practice - Conclusion and take home message
Source: Annual Congress 2004 - How can we improve asthma management?
Year: 2004
Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013
Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017
Digital home resources in clinical trial management
Source: Virtual Congress 2021 – Digital health and innovation
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept